These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38577570)

  • 1. Tumor growth manifested in two-fifths of low-risk papillary thyroid microcarcinoma patients during active surveillance: data from a tertiary center in China.
    Le K; Jin L; Zhong F; Huang X; Zhou L; Zhou J; Xie L
    Front Endocrinol (Lausanne); 2024; 15():1359621. PubMed ID: 38577570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in active surveillance for adult low-risk papillary thyroid microcarcinoma].
    Liu J; Xu C; Yao X; Zhao R; Zhang S
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2023 Feb; 37(2):150-156. PubMed ID: 36756834
    [No Abstract]   [Full Text] [Related]  

  • 3. Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.
    Kim CA; Baek SH; Yoo J; Chung SR; Baek JH; Chung KW; Kim WB; Jeon MJ; Kim WG
    Thyroid; 2024 Jul; 34(7):846-855. PubMed ID: 38757584
    [No Abstract]   [Full Text] [Related]  

  • 4. Natural history of papillary thyroid microcarcinoma: Kinetic analyses on tumor volume during active surveillance and before presentation.
    Miyauchi A; Kudo T; Ito Y; Oda H; Yamamoto M; Sasai H; Higashiyama T; Masuoka H; Fukushima M; Kihara M; Miya A
    Surgery; 2019 Jan; 165(1):25-30. PubMed ID: 30413323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications and Strategy for Active Surveillance of Adult Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements from the Japan Association of Endocrine Surgery Task Force on Management for Papillary Thyroid Microcarcinoma.
    Sugitani I; Ito Y; Takeuchi D; Nakayama H; Masaki C; Shindo H; Teshima M; Horiguchi K; Yoshida Y; Kanai T; Hirokawa M; Hames KY; Tabei I; Miyauchi A
    Thyroid; 2021 Feb; 31(2):183-192. PubMed ID: 33023426
    [No Abstract]   [Full Text] [Related]  

  • 6. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea.
    Kwon H; Oh HS; Kim M; Park S; Jeon MJ; Kim WG; Kim WB; Shong YK; Song DE; Baek JH; Chung KW; Kim TY
    J Clin Endocrinol Metab; 2017 Jun; 102(6):1917-1925. PubMed ID: 28323932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active Surveillance of Low-Risk Papillary Thyroid Microcarcinoma: A Multi-Center Cohort Study in Korea.
    Oh HS; Ha J; Kim HI; Kim TH; Kim WG; Lim DJ; Kim TY; Kim SW; Kim WB; Shong YK; Chung JH; Baek JH
    Thyroid; 2018 Dec; 28(12):1587-1594. PubMed ID: 30226447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression of Low-Risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim Analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma in Korea.
    Lee EK; Moon JH; Hwangbo Y; Ryu CH; Cho SW; Choi JY; Chung EJ; Jeong WJ; Jung YS; Ryu J; Kim SJ; Kim MJ; Kim YK; Lee CY; Lee JY; Yu HW; Hah JH; Lee KE; Lee YJ; Park SK; Park DJ; Kim JH; Park YJ
    Thyroid; 2022 Nov; 32(11):1328-1336. PubMed ID: 36205563
    [No Abstract]   [Full Text] [Related]  

  • 9. Active Surveillance as an Effective Management Option for Low-Risk Papillary Thyroid Microcarcinoma.
    Jeon MJ; Kim WG; Kim TY; Shong YK; Kim WB
    Endocrinol Metab (Seoul); 2021 Aug; 36(4):717-724. PubMed ID: 34379969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.
    Sugitani I; Ito Y; Miyauchi A; Imai T; Suzuki S
    Thyroid; 2019 Nov; 29(11):1563-1571. PubMed ID: 31441377
    [No Abstract]   [Full Text] [Related]  

  • 11. Papillary thyroid microcarcinoma: Is active surveillance always enough?
    Sutherland R; Tsang V; Clifton-Bligh RJ; Gild ML
    Clin Endocrinol (Oxf); 2021 Dec; 95(6):811-817. PubMed ID: 34021503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor volume-doubling rate is negatively associated with patient age in papillary thyroid microcarcinomas under active surveillance.
    Yamamoto M; Miyauchi A; Ito Y; Fujishima M; Sasaki T; Kudo T
    Surgery; 2024 Apr; 175(4):1089-1094. PubMed ID: 38142143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic Analysis of Growth Activity in Enlarging Papillary Thyroid Microcarcinomas.
    Ito Y; Miyauchi A; Kudo T; Higashiyama T; Masuoka H; Kihara M; Miya A
    Thyroid; 2019 Dec; 29(12):1765-1773. PubMed ID: 31650907
    [No Abstract]   [Full Text] [Related]  

  • 14. BRAF V600E status may facilitate decision-making on active surveillance of low-risk papillary thyroid microcarcinoma.
    Kim KJ; Kim SG; Tan J; Shen X; Viola D; Elisei R; Puxeddu E; Fugazzola L; Colombo C; Jarzab B; Czarniecka A; Lam AK; Mian C; Vianello F; Yip L; Riesco-Eizaguirre G; Santisteban P; O'Neill CJ; Sywak MS; Clifton-Bligh R; Bendlova B; Sýkorová V; Xing M
    Eur J Cancer; 2020 Jan; 124():161-169. PubMed ID: 31790974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active surveillance of low-risk papillary thyroid microcarcinomas in Japan and other countries: a review.
    Ito Y; Miyauchi A
    Expert Rev Endocrinol Metab; 2020 Jan; 15(1):5-12. PubMed ID: 31902250
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Jin M; Kim HI; Ha J; Jeon MJ; Kim WG; Lim DJ; Kim TY; Chung JH; Shong YK; Kim TH; Kim WB
    Thyroid; 2021 Oct; 31(10):1494-1501. PubMed ID: 34225475
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of Initial Treatment Choice on 2-year Quality of Life in Patients with Low-risk Papillary Thyroid Microcarcinoma.
    Moon JH; Ryu CH; Cho SW; Choi JY; Chung EJ; Hah JH; Hwangbo Y; Jeong WJ; Jung YS; Kim JH; Kim MJ; Kim SJ; Kim YK; Lee CY; Lee EK; Lee JY; Lee KE; Lee YJ; Lee Y; Yu HW; Park DJ; Ryu J; Park YJ
    J Clin Endocrinol Metab; 2021 Mar; 106(3):724-735. PubMed ID: 33248442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
    Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
    J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The occurrence of and predictive factors for multifocality and bilaterality in patients with papillary thyroid microcarcinoma.
    Kaliszewski K; Diakowska D; Wojtczak B; Migoń J; Kasprzyk A; Rudnicki J
    Medicine (Baltimore); 2019 May; 98(19):e15609. PubMed ID: 31083255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance as a management strategy for papillary thyroid microcarcinoma.
    Zhang H; Zheng X; Liu J; Gao M; Qian B
    Cancer Biol Med; 2020 Aug; 17(3):543-554. PubMed ID: 32944389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.